CL2008001806A1 - Composicion de vacuna en emulsion agua en aceite que comprende un antigeno y un adyuvante en la fase acuosa; y metodo de elaboracion. - Google Patents

Composicion de vacuna en emulsion agua en aceite que comprende un antigeno y un adyuvante en la fase acuosa; y metodo de elaboracion.

Info

Publication number
CL2008001806A1
CL2008001806A1 CL200801806A CL2008001806A CL2008001806A1 CL 2008001806 A1 CL2008001806 A1 CL 2008001806A1 CL 200801806 A CL200801806 A CL 200801806A CL 2008001806 A CL2008001806 A CL 2008001806A CL 2008001806 A1 CL2008001806 A1 CL 2008001806A1
Authority
CL
Chile
Prior art keywords
elaboration
vaccine
adjuster
antigen
oil
Prior art date
Application number
CL200801806A
Other languages
English (en)
Inventor
Evan James Lutz David Le Diehl
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of CL2008001806A1 publication Critical patent/CL2008001806A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/145Orthomyxoviridae, e.g. influenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55555Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55561CpG containing adjuvants; Oligonucleotide containing adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55572Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16171Demonstrated in vivo effect
CL200801806A 2007-06-20 2008-06-18 Composicion de vacuna en emulsion agua en aceite que comprende un antigeno y un adyuvante en la fase acuosa; y metodo de elaboracion. CL2008001806A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US93657107P 2007-06-20 2007-06-20

Publications (1)

Publication Number Publication Date
CL2008001806A1 true CL2008001806A1 (es) 2008-09-05

Family

ID=39720537

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200801806A CL2008001806A1 (es) 2007-06-20 2008-06-18 Composicion de vacuna en emulsion agua en aceite que comprende un antigeno y un adyuvante en la fase acuosa; y metodo de elaboracion.

Country Status (26)

Country Link
US (2) US8980288B2 (es)
EP (1) EP2164510B1 (es)
JP (2) JP5457340B2 (es)
KR (1) KR101569218B1 (es)
CN (2) CN105148268A (es)
AR (1) AR067087A1 (es)
AU (1) AU2008265745B2 (es)
BR (1) BRPI0812856A2 (es)
CA (1) CA2692098C (es)
CL (1) CL2008001806A1 (es)
CO (1) CO6251273A2 (es)
CY (1) CY1114451T1 (es)
DK (1) DK2164510T3 (es)
ES (1) ES2429296T3 (es)
HK (1) HK1218717A1 (es)
HR (1) HRP20130939T1 (es)
ME (1) ME01527B (es)
MX (1) MX2009014070A (es)
NZ (1) NZ582132A (es)
PL (1) PL2164510T3 (es)
PT (1) PT2164510E (es)
RS (1) RS52947B (es)
SI (1) SI2164510T1 (es)
TW (1) TWI507214B (es)
WO (1) WO2008157659A1 (es)
ZA (1) ZA200909173B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2008001806A1 (es) * 2007-06-20 2008-09-05 Wyeth Corp Composicion de vacuna en emulsion agua en aceite que comprende un antigeno y un adyuvante en la fase acuosa; y metodo de elaboracion.
CN104001170B (zh) 2008-06-27 2016-08-24 硕腾有限责任公司 新颖的佐剂组合物
WO2010114169A1 (en) * 2009-03-31 2010-10-07 Japan As Represented By The Director-General Of National Institute Of Infectious Diseases Method for prophylaxis of influenza using vaccine for intranasal administration
DE112011100387B4 (de) 2010-01-29 2022-07-14 Donaldson Company, Inc. Wasserabscheider-Aufbau zur Verwendung mit einem Luftfilter, Motorluftstrom-Einlassanordnung, Fahrzeug und Verfahren
CN101829323A (zh) * 2010-04-28 2010-09-15 洛阳普莱柯生物工程有限公司 一种禽用油乳剂疫苗及其制备方法
US20140113817A1 (en) 2011-04-12 2014-04-24 Unaio Brasiliense De Educaco E Cultura-Ubec Peptides with antimicrobial activity, drug compositions for the treatment and prophylaxis of animals, compositions for the treatment and prophylaxis of plants, uses of said peptides, and uses of paenibacillus elgil ourofinensis extract
NZ757210A (en) 2013-09-19 2022-12-23 Zoetis Services Llc Oil-based adjuvants
MX2016007356A (es) * 2013-12-06 2016-10-03 Advanced Bionutrition Corp Composicion para administracion oral de agentes bioactivos.
LT3244920T (lt) 2015-01-16 2023-08-25 Zoetis Services Llc Snukio ir nagų ligos vakcina
GB201506948D0 (en) * 2015-04-23 2015-06-10 Croda Int Plc Emulsions for injectable formulations
CN106177939B (zh) * 2015-06-01 2021-01-19 普莱柯生物工程股份有限公司 一种疫苗用佐剂及其应用
CN106344920B (zh) * 2015-07-16 2020-11-27 普莱柯生物工程股份有限公司 一种疫苗用佐剂及其应用
CN107281482B (zh) * 2016-04-05 2021-06-11 普莱柯生物工程股份有限公司 一种免疫佐剂组合物及其制备方法
US11351249B2 (en) * 2018-03-13 2022-06-07 Capsular Technologies Pty Ltd Vaccine compositions comprising a water-in-oil emulsion, immunogen-loaded hydrogel particles, and cationic polymer
CN110404065B (zh) * 2018-04-27 2023-06-16 洛阳赛威生物科技有限公司 一种猪用佐剂组合物及其制备方法
CA3106341A1 (en) * 2018-07-13 2020-01-16 Biomune Company New vaccines against avian reoviruses
WO2020023950A1 (en) 2018-07-27 2020-01-30 Research Development Foundation Chimeric immunogenic polypeptides
CN114306585A (zh) * 2021-12-30 2022-04-12 广西壮族自治区水产科学研究院 一种鱼类高纯度抗原乳剂的制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639577A (en) * 1968-02-23 1972-02-01 Haver Lockhart Lab Inc Injectable adjuvant,method of preparing same and compositions including such adjuvant
NZ221306A (en) * 1986-08-15 1990-02-26 Commw Scient Ind Res Org 2-component immunoadjuvant comprising a mycobacterial free immunoadjuvant oil and a polycationic polyelectrolyte immunoadjuvant and vaccines thereof
ES2037072T3 (es) * 1986-12-19 1993-06-16 Duphar International Research B.V Suspension coadyuvante estabilizada que comprende bromuro de dimetil-dioctadecil-amonio.
US5951988A (en) * 1993-03-30 1999-09-14 University Of Saskatchewan Adjuvant formulation with enhanced immunogenic activity, and related compositions and methods
BE1008977A5 (fr) * 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
US5744137A (en) * 1995-02-06 1998-04-28 The United States Of America As Represented By The Secretary Of The Agriculture Oil emulsion vaccines prepared with animal, vegetable, and synthetic oils using a mixture of nonionic surfactants
JP4918188B2 (ja) * 1997-12-16 2012-04-18 ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド サブミクロンの水中油型エマルジョンと合わせた微粒子の使用
FR2775601B1 (fr) * 1998-03-03 2001-09-21 Merial Sas Vaccins vivants recombines et adjuves
FR2776928B1 (fr) * 1998-04-03 2000-06-23 Merial Sas Vaccins adn adjuves
WO2001089559A2 (en) * 2000-05-24 2001-11-29 Merial Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccine
FR2810888B1 (fr) * 2000-06-29 2004-07-30 Merial Sas Vaccin contre la fievre aphteuse
US6585978B1 (en) * 2000-09-09 2003-07-01 Akzo Nobel EIA vaccine and diagnostic
US7018638B2 (en) * 2000-12-19 2006-03-28 Wyeth Mycoplasma hyopneumoniae bacterin vaccine
US6676958B2 (en) * 2001-06-19 2004-01-13 Advanced Bioadjuvants, Llc Adjuvant composition for mucosal and injection delivered vaccines
US20030129161A1 (en) * 2001-09-17 2003-07-10 Hsien-Jue Chu Interleukin-12 as a veterinary vaccine adjuvant
JP3812814B2 (ja) * 2001-10-19 2006-08-23 株式会社微生物化学研究所 動物用多価オイルアジュバントワクチン
US7862821B2 (en) * 2006-06-01 2011-01-04 Merial Limited Recombinant vaccine against bluetongue virus
CL2008001806A1 (es) * 2007-06-20 2008-09-05 Wyeth Corp Composicion de vacuna en emulsion agua en aceite que comprende un antigeno y un adyuvante en la fase acuosa; y metodo de elaboracion.

Also Published As

Publication number Publication date
JP5802285B2 (ja) 2015-10-28
JP5457340B2 (ja) 2014-04-02
EP2164510A1 (en) 2010-03-24
CO6251273A2 (es) 2011-02-21
US8980288B2 (en) 2015-03-17
AR067087A1 (es) 2009-09-30
JP2014088423A (ja) 2014-05-15
BRPI0812856A2 (pt) 2014-12-09
CN101790378A (zh) 2010-07-28
CA2692098C (en) 2016-06-14
RS52947B (en) 2014-02-28
KR20100022115A (ko) 2010-02-26
WO2008157659A1 (en) 2008-12-24
MX2009014070A (es) 2010-05-19
AU2008265745B2 (en) 2013-05-30
CA2692098A1 (en) 2008-12-24
US20090017067A1 (en) 2009-01-15
ES2429296T3 (es) 2013-11-14
US9545439B2 (en) 2017-01-17
TWI507214B (zh) 2015-11-11
SI2164510T1 (sl) 2013-11-29
ZA200909173B (en) 2010-08-25
ME01527B (me) 2014-04-20
AU2008265745A1 (en) 2008-12-24
PL2164510T3 (pl) 2014-03-31
HK1218717A1 (zh) 2017-03-10
PT2164510E (pt) 2013-10-07
HRP20130939T1 (hr) 2013-11-22
KR101569218B1 (ko) 2015-11-13
US20150297710A1 (en) 2015-10-22
EP2164510B1 (en) 2013-07-17
NZ582132A (en) 2012-04-27
TW200906448A (en) 2009-02-16
CN105148268A (zh) 2015-12-16
DK2164510T3 (da) 2013-09-23
JP2010530877A (ja) 2010-09-16
CY1114451T1 (el) 2016-10-05

Similar Documents

Publication Publication Date Title
CL2008001806A1 (es) Composicion de vacuna en emulsion agua en aceite que comprende un antigeno y un adyuvante en la fase acuosa; y metodo de elaboracion.
DK2086582T3 (da) Vaccine omfattende en olie-i-vand-emulsionsadjuvans
BRPI0813092A2 (pt) Composição de emulsão óleo em água e método para produzir a mesma.
ATE528995T1 (de) Wasser-in-öl süsswarenemulsion mit geringem fettgehalt
DK1758556T3 (da) Olie-i-vand-emulsion til fremføring
BRPI0920565A2 (pt) emulsão de óleo em água
HK1141712A1 (en) Oil-in-water emulsion composition and method for producing the same
BRPI0923338A2 (pt) aparelho e método para avaliação de fluidos de fundo de poço.
BRPI0807667A2 (pt) Composição emulsificada de óleo-em-água
FR2896162B1 (fr) Emulsion huile dans eau thermoreversible
CL2007002965A1 (es) Metodo y sistema para entregar y ejecutar las mejores practicas en proyectos de desarrollo de yacimiento petrolifero.
FR2921262B1 (fr) Emulsion cosmetique de type huile dans eau
BRPI0820799A2 (pt) Método e sistema para misturar um fluido de tratamento de poço em emulsão
BRPI0815302A2 (pt) "método e sistema para determinação de compatibilidade"
BRPI0918783A2 (pt) formulações de desemulsificantes de anidrido para resolução de emulsões de água e óleo
BR112012001826A2 (pt) emulsão óleo-em-água que possui propriedades sensoriais aprimoradas
HK1110516A1 (en) Solid oil-in-water emulsion
DE602005001478D1 (de) Oel-in-Wasser emulgierte Zusammensetzung
BRPI0912117A2 (pt) copolímero ramificado anfifílico, métodos para preparar um copolímero anfifílico ramificado e uma emulsão, emulsão de óleo/água, e, uso de um copolímero ramificado
FR2901124B1 (fr) Emulsion huile dans eau fine
BRPI0819660A2 (pt) Método e sistema educacional que inclui pelo menos uma interface de usuário
BRPI0906080A2 (pt) Metodos e sistema para avaliar a quantidade de óleo para fritura
BRPI0816066A2 (pt) método de prevenção de nefrocalcinose
FR2896151B1 (fr) Composition d'emulsion de type huile-dans-eau encapsulee
ATE366101T1 (de) Wachsmikropartikel enthaltende schweisshemmende zusammensetzung in form einer öl-in-wasser emulsion